-
Using Machine Learning to Identify Key Predictors of Health-Related Quality of Life in Older Women with Early-Stage Breast Cancer Undergoing Endocrine Therapy
Mar 10, 2025, 14:00 PM -
US Food and Drug Administration Authorizations of Therapeutic Biologics and Biosimilars, 1980-2024
Mar 10, 2025, 14:00 PM -
Cost Effectiveness of Pembrolizumab in Combination with Chemotherapy for the Treatment of Patients with Locally Advanced or Metastatic HER2-Negative Gastric or Gastroesophageal Cancer in Mexico
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns Among Patients With Scalp Psoriasis in Canada
Mar 10, 2025, 14:00 PM -
Trends in Vaccinations by Medicare Part D Beneficiaries
Mar 10, 2025, 14:00 PM -
Psychometric Analysis of the EORTC QLQ-NMIBC24 Using Data from a Global Phase 2 Randomized Trial of Erdafitinib[1] in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Mar 10, 2025, 14:00 PM -
A New-to-Market Single-Use Ureteroscope: Urologist Performance Rating and Capability Assessment
Mar 10, 2025, 14:00 PM -
Household Costs and Other Societal Impacts for Individuals With Duchenne Muscular Dystrophy Stratified by Upper Limb Impairment: Results From a Caregiver Survey
Mar 10, 2025, 14:00 PM -
Treatment Patterns, Healthcare Resource Utilization, and Healthcare Costs Among Patients with Metastatic Gastric/Gastroesophageal Junction Cancer in Commercially Insured Patients in the United States
Mar 10, 2025, 14:00 PM -
Fostering the Identification and Dissemination ofHealth Technology Assessment Studies: The Brazilian HTA Database Case Study
Mar 10, 2025, 14:00 PM -
Outcomes In Patients With Asthma and Coexisting Allergic Rhinitis Who Started Dupilumab Treatment In Real-World Clinical Practice: A RAPID Registry Study
Mar 10, 2025, 14:00 PM -
Examining Patterns in Breast Cancer Patient Characteristics and Treatment Throughout the COVID-19 Pandemic
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Next-Generation Sequencing Technologies in Paediatric Patient Groups With Rare Diseases: a Systematic Review
Mar 10, 2025, 14:00 PM -
Healthcare Cost and Resource Utilization among First Line (1L) Treated Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC): Analysis of SEER-Medicare Linked Claims in the US
Mar 10, 2025, 14:00 PM -
MetaSLR: AI-Driven Screening and Extraction Platform with Integrated Quality Assurance Checkpoints
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Atezolizumab Plus Chemotherapy for Treatment-Naive Patients of Extensive-Stage Small Cell Lung Cancer without Brain Metastasis
Mar 10, 2025, 14:00 PM -
A Different Approach to the Overall Survival Conversation: A Bayesian Analysis of Overall Survival Benefits Among Oncology Accelerated Approvals
Mar 10, 2025, 14:00 PM -
Cost Opportunity of Polatuzumab Vedotin as First-Line Therapy for DLBCL on Subsequent Treatments - Brazilian Cost Analysis
Mar 10, 2025, 14:00 PM -
Epidemiology and Disease Burden of Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, and Systemic Inflammation in Northern China: A Retrospective Study of Tianjin Regional Electronic Health Records
Mar 10, 2025, 14:00 PM -
Evaluation of the Cost of Treatment on Endometriosis in the Hungarian Public-Funded Healthcare System
Mar 10, 2025, 14:00 PM
